Pfizer Seeking Emergency Use of its COVID-19 Vaccine


Pfizer today asked U.S. regulators to allow emergency use of its COVID-19 vaccine. Such approval would allow Pfizer to begin a limited distribution of its vaccine before the end of the year. It appears that around 25 million doses could be available for use in December, with 30 million in January, and 35 million in February and in March. This comes after Pfizer announced that its vaccine appears to be 95% effective at preventing COVID-19. 

The drug maker Moderna is expected to also seek emergency authorization for its COVID-19 vaccine in the next few weeks. Pfizer's and Moderna's vaccines both rely on a new RNA technology that does not rely on any cells for its production. While vaccines are typically developed by placing a virus inside cells, these vaccines are developed using mRNA molecules that prompt an individual's own cells to produce the necessary protein to create an immune response. As this technology does not rely on cells for its production, it means that fetal cells are not used. According to the pro-life research group, the Charlotte Lozier Institute, both the Pfizer and Moderna vaccines are "ethically uncontroversial."  To read more about the development of the Pfizer and Moderna vaccines, please see this article from Aleteia.

November 20, 2020 - 4:20pm

Latest Posts

Governor Parson Grants Additional Pardons

Governor Parson recently issued 17 pardons and approved one commutation pursuant to Article IV, section 7 of the Constitution of the State of Missouri....Read more

Missouri Increases Vaccination Numbers

As of April 8, Missouri reported 1.8 million of its residents have received a first dose of the COVID-19 vaccine, or 29% of the...Read more

Senate Approves Foster Care and Adoption Bills

On Thursday, the Senate third read and passed two bills that would provide tax relief for families who adopt or provide foster care services....Read more

Subscribe to Blog
  • 1 of 248